UK Leaders
Sales and Marketing/ Views & Analysis/ Views and analysis
GSK’s Neale Belson on building trust with employees and society
George Underwood
climate change, GSK, reputation, Sustainability, UK Leaders
0 Comment
Market Access/ Views & Analysis/ Views and analysis
Vertex Pharma’s vision for reimbursement innovation
Paul Tunnah
COVID-19, cystic fibrosis, EU Leaders, NICE, reimbursement, UK Leaders, Vertex Pharma
0 Comment
Ipsen’s UK & Ireland MD on adapting business to COVID-19
mike.hammerton@pharmaphorum.com
business, COVID-19, Ipsen, UK, UK Leaders
0 Comment
Digital/ Market Access/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis
Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes
Market Access/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis
MSD’s David Peacock on moving UK healthcare forward
mike.hammerton@pharmaphorum.com
coronavirus, COVID-19, Merck, Merck & Co, MSD, NHS, UK, UK Leaders
0 Comment
Market Access/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis
Teva’s Kim Innes on shaping the post-COVID future with the NHS
George Underwood
coronavirus, COVID-19, generics, NHS, NICE, Teva, UK Leaders
0 Comment
R&D/ Views & Analysis/ Views and analysis
Janssen’s Gaëtan Leblay on leading during the COVID-19 crisis
Paul Tunnah
coronavirus, COVID-19, J&J, Janssen, UK Leaders
0 Comment
Market Access/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis
Daiichi Sankyo: pharma needs to become NHS ‘experts’
George Underwood
Daiichi Sankyo, NHS, pricing, UK Leaders
0 Comment